Adaptive Autism Intervention for Toddlers with Autism
(CAIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find the best mix of interventions to help toddlers with autism improve their social, language, and cognitive skills. It uses a program called JASPER (Joint Attention Symbolic Play Engagement & Regulation), which focuses on social communication through play. Toddlers begin with daily sessions and, based on their progress, may continue with JASPER or add other activities to boost their growth. This trial includes toddlers diagnosed with autism who are part of a community-based early intervention program, and caregivers can learn the strategies if needed. As an unphased trial, it offers families a unique opportunity to explore innovative strategies that could significantly enhance their child's developmental progress.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It focuses on behavioral interventions for toddlers with autism.
Do I have to stop my child's current medications for this trial?
The trial protocol does not specify whether participants must stop taking their current medications, so it's best to discuss this with the trial coordinators or your child's doctor.
What prior data suggests that these interventions are safe for toddlers with autism?
Research shows that the JASPER program is generally well-received by children with autism. Studies have found that children participating in JASPER sessions made significant progress in areas like shared attention and communication skills. These studies reported no major negative effects, indicating that JASPER is a safe option for young children with autism. As a type of behavioral therapy rather than medication, JASPER avoids many side effects associated with drugs. Overall, evidence supports JASPER as a safe and helpful approach for toddlers with autism.12345
Why are researchers excited about this trial?
Researchers are excited about JASPER for toddlers with autism because it offers a tailored approach that adapts to each child's response. Unlike traditional methods like ABA therapy, which often follow a more rigid structure, JASPER is flexible, allowing for adjustments based on whether a child is an early or slow responder. This personalization can lead to more effective, engaging sessions that nurture the child's unique developmental needs. Additionally, JASPER focuses on enhancing social communication through play, which is a natural and enjoyable way for toddlers to learn, potentially leading to better outcomes.
What evidence suggests that this trial's treatments could be effective for toddlers with autism?
Research has shown that JASPER, a program designed to aid social communication, yields promising results for young children with autism. Most studies have found that children participating in JASPER improve in at least one developmental area, such as social communication skills. JASPER specifically enhances joint attention, which involves focusing on the same thing as someone else—an essential skill for social interaction. In some studies, improvements in joint attention significantly contributed to better social communication. Caregivers also observed that children became more engaged and better behaved during play, underscoring JASPER's potential to help toddlers with autism develop crucial social skills. In this trial, participants will be randomized to receive JASPER for either 6 weeks or 12 weeks, with adjustments based on their response to the intervention.12367
Are You a Good Fit for This Trial?
This trial is for toddlers aged 2-3 with autism spectrum disorder (ASD) who are receiving early intervention in East Harlem and the Bronx, NY. They must have a clinical ASD diagnosis or ADOS-2 confirmation, and their caregivers must consent to learn intervention strategies if required. Children with co-morbid disorders like cerebral palsy or Down syndrome cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Stage 1 Treatment
Participants receive JASPER intervention for either 6 or 12 weeks, depending on randomization
Stage 2 Treatment
Participants continue with JASPER or are augmented with JASPER Plus+ based on response
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- jasPEER
- JASPER
- JASPER Plus+
- Structured Teaching
JASPER is already approved in United States for the following indications:
- Autism Spectrum Disorder (ASD), specifically for improving social communication and play skills in minimally verbal children
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
National Institutes of Health (NIH)
Collaborator